Makers Laboratories (MAKERSL) will issue Rights Entitlements (REs) to anyone who holds its shares as of April 1, 2022 (record date). You will be eligible to receive Rights Entitlements (REs) if you have bought the shares on or before March 29, 2022. The ex-date is March 30, 2022.
These REs will be temporarily traded on the stock exchanges and will then be extinguished. You can either use the REs to apply for the rights shares of Makers Laboratories or you can sell them in the market. You can check the announcement from the company here.
Issue Details
| Ex-date | March 30, 2022 |
| Record Date | April 1, 2022 |
| Ratio | 1:5 |
| Issue Price | ₹ 150 per share |
| Issue Period | April 18, 2022 to April 27, 2022 |
| RE Trading Period | April 18, 2022 to April 22, 2022 |
| Tentative date of allotment | May 6, 2022 |
| Tentative date of listing | May 11, 2022 |
How to apply for the Makers Laboratories Rights Issue?
Once you either receive the REs from the company or purchase them from the market, you can apply for the rights shares using Netbanking ASBA or offline by submitting a Application Form to the Designated Branch of the SCSB (Self Certificate Syndicate Bank). You can check the process in this post.
You will need to enter your demat account’s Beneficiary Owner ID which is a 16-digit number while applying for the rights issue.
What will happen to my purchased holding of RE shares if I do not apply for the rights issue?
Your REs will lapse and you will lose the premium paid to acquire them. The RE will be in the form of temporary demat securities which will lapse if not renounced/exercised once the trading window is closed.
I don’t have the shares but bought REs, am I still eligible to apply for the rights issue?
In case you have bought REs but don’t have shares, you’re still eligible for the rights issue. You may apply for the rights shares either through the RTA’s portal or via net banking ASBA if your bank allows it. If you don’t take any action, and let the REs remain in your Zerodha account, they will lapse after the issue.
You can read more FAQ’s on Rights Issue and Rights Entitlements here.